ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288 | +2.5% | 21,937 | -1.5% | 0.01% | +9.1% |
| Q2 2023 | $281 | -3.8% | 22,281 | -0.6% | 0.01% | -8.3% |
| Q1 2023 | $292 | -26.4% | 22,407 | -0.4% | 0.01% | -29.4% |
| Q4 2022 | $397 | -99.9% | 22,486 | -15.8% | 0.02% | +6.2% |
| Q3 2022 | $407,000 | -18.8% | 26,710 | -21.0% | 0.02% | +6.7% |
| Q2 2022 | $501,000 | -55.7% | 33,796 | -32.8% | 0.02% | -44.4% |
| Q1 2022 | $1,132,000 | +6.3% | 50,280 | -12.9% | 0.03% | +22.7% |
| Q4 2021 | $1,065,000 | +38.7% | 57,727 | +0.5% | 0.02% | +29.4% |
| Q3 2021 | $768,000 | -30.7% | 57,440 | -4.1% | 0.02% | -19.0% |
| Q2 2021 | $1,109,000 | +30.3% | 59,910 | +5.7% | 0.02% | +23.5% |
| Q1 2021 | $851,000 | +3.4% | 56,660 | -0.6% | 0.02% | 0.0% |
| Q4 2020 | $823,000 | +77.4% | 56,990 | 0.0% | 0.02% | +54.5% |
| Q3 2020 | $464,000 | +20.2% | 56,990 | 0.0% | 0.01% | +10.0% |
| Q2 2020 | $386,000 | – | 56,990 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |